Stamford, Connecticut Wednesday, March 12, 2025, 15:00 Hrs [IST] ...

The US Food and Drug Administration (FDA) has given the greenlight to Caristo Diagnostics for CaRi-Plaque, an artificial ...

The CaRi-Plaque technology supports non-invasive analysis of coronary anatomy and pathology from routine coronary computed ...

FDA 510(k) clearance of Caristo's CaRi-Plaque technology advances AI innovator's U.S. commercialization, as it looks to roll out to hospitals, health systems and longevity clinicsThe CaRi-Plaque ...

Statins and blood pressure medications slow this progression, but many heart attacks happen in arteries that ... invasive analysis of coronary anatomy and pathology from routine coronary computed ...

Composite of coronary heart disease death and non-fatal myocardial infarction was less frequent in the CCTA group compared to ...

Bindman, a professor at the University of California-San Francisco medical school, has spent well over a decade researching ...

Coronary artery disease, CAD, is a condition where the arteries that supply blood to the heart muscle become clogged and narrow, making it difficult for blood and oxygen to reach the muscles of ...

Despite insufficient evidence to support direct-to-consumer genetic testing in routine clinical care, cardiovascular clinicians increasingly face questions about its utility and interpretation because ...

Mar. 12, 2025 — In developing hearts, cells shuffle around, bumping into each other to find their place, and the stakes are high: pairing with the wrong cell could mean the difference between a ...